Concepedia

Suraya Elfrink

SE

4

Publications

115

Citations

4

H-Index

2016

Active since

Affiliations

Radboud University Medical Center(Current)

Radboud Institute for Molecular Life Sciences

Radboud University Nijmegen

Oncode Institute

Amsterdam University Medical Centers

Suraya Elfrink is an author at Radboud University Medical Center specializing in tumor biology, cancer research, and cell biology.

ORCID

Top concepts

Publications per year

2016–2022

4

Publications

4

Tetraspanin CD37 protects against the development of B cell lymphoma

Charlotte M. de Winde, Sharon Veenbergen, Ken H. Young et al. · Journal of Clinical Investigation · 2016 · 59 citations · Full text

, , +14

CRISPR-induced RASGAP deficiencies in colorectal cancer organoids reveal that only loss of NF1 promotes resistance to EGFR inhibition

Jasmin B. Post, Nizar Hami, Alexander E.E. Mertens et al. · Oncotarget · 2019 · 22 citations · Full text

, , +15

High frequency of inactivating tetraspanin CD37 mutations in diffuse large B-cell lymphoma at immune-privileged sites

Suraya Elfrink, Charlotte M. de Winde, Michiel van den Brand et al. · Blood · 2019 · 22 citations · Full text

IRF8 is a transcriptional activator of CD37 expression in diffuse large B-cell lymphoma

Suraya Elfrink, Martin ter Beest, Luuk Janssen et al. · Blood Advances · 2022 · 12 citations · Full text

Rows per page

1–4 of 4